NCT05078762

Brief Summary

The purpose of this single-center randomized study is to investigate whether bronchoscopy training in an immersive Virtual Reality (iVR) environment will make the surgeon better at handling distractions and increase the quality of the bronchoscopy. The participants will be stratified according to gender and randomized into two groups. Both groups will initially train on the bronchoscopy simulator without VR. Afterwards the intervention group will train in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles. Afterwards both groups will be tested in the iVR environment in a test scenario

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

October 4, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 14, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

March 9, 2022

Status Verified

March 1, 2022

Enrollment Period

4 months

First QC Date

September 22, 2021

Last Update Submit

March 7, 2022

Conditions

Keywords

Bronchoscopy TrainingImmersive Simulation Training

Outcome Measures

Primary Outcomes (2)

  • Structured Progress

    The systematic visualization and structured passage through the bronchial tree measured in points (0-18 points)

    From beginning to end of each procedure, aprox. 30 minutes

  • Procedure time

    Time (seconds) from passing the vocal cords to retraction of the endoscope.

    From beginning to end of each procedure, aprox. 30 minutes

Secondary Outcomes (6)

  • Motor Bronchoscopy Skill Score

    From beginning to end of each procedure, aprox. 30 minutes

  • Diagnostic completeness

    From beginning to end of each procedure, aprox. 30 minutes

  • Heart Rate Variability(LF/HF ratio)

    From beginning to end of each procedure, aprox. 30 minutes

  • Eye movement measurements

    From beginning to end of each procedure, aprox. 30 minutes

  • Eye movement measurements

    From beginning to end of each procedure, aprox. 30 minutes

  • +1 more secondary outcomes

Study Arms (2)

iVR

EXPERIMENTAL

The intervention group will train on a bronchoscopy simulator in an iVR environment with Virtual Reality Goggles (HTC IVE Pro Eye, HTC corporation, Taiwan) while using the bronchoscopy simulator.

Other: Immersive Virtual Reality

Non iVR

NO INTERVENTION

The control group will train on a bronchoscopy simulator without VR goggles.

Interventions

Training in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles.

Also known as: iVR
iVR

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsBased on a self-report form
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Residents working in Denmark in thoracic surgery and pulmonary medicine
  • Participants are required to have a medical license.

You may not qualify if:

  • Previous participation in trials involving bronchoscopy training.
  • Experience with independent bronchoscopy.
  • No informed consent.
  • Unable to speak Danish on a conversational level.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Copenhagen Academy for Medical Education and Simulation

Copenhagen, 2100, Denmark

Location

Study Officials

  • Lars Konge, Professor, MD, PHD

    Copenhagen Academy for Medical Education and Simulation

    STUDY CHAIR
  • Flemming Bjerrum, MD, PhD

    Copenhagen Academy for Medical Education and Simulation

    STUDY DIRECTOR
  • Annarita G Andersen, BMed

    Copenhagen Academy for Medical Education and Simulation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants will not be blinded to the main investigator, as this is impossible due to the nature of the trial. The statistical analysis will be performed blinded and by someone other than the principal investigator.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Randomization is performed online using SealedEnvelope™ (Sealed Envelope ltd, London, UK) before the start of the trial. The participants are stratified by sex (man/woman) as this has been seen to influence skills acquisition during the early part of in the learning curve
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 22, 2021

First Posted

October 14, 2021

Study Start

October 4, 2021

Primary Completion

January 30, 2022

Study Completion

February 28, 2022

Last Updated

March 9, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations